Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells

Brain Research

Volumn 866, Issue 1-2, 2000, Pages 33-43

  Zhou, Wenbo ^a   Huribert, Marc S ^a   Schaack, Jerome ^b   Prasad, Kedar N ^a   Freed, Curt R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Synuclein; 6 Hydroxydopamine; Adenovirus; Dopamine neuron; Neurotoxicity; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; OXIDOPAMINE;

ADENOVIRUS; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; FEMALE; GENE OVEREXPRESSION; HUMAN TISSUE; MALE; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; ALPHA-SYNUCLEIN; ANIMALS; APOPTOSIS; CELL LINE, TRANSFORMED; DOPAMINE; EMBRYO; GENE TRANSFER TECHNIQUES; HUMANS; MESENCEPHALON; MUTATION; NERVE TISSUE PROTEINS; NEURONS; NEUROTOXINS; OXIDOPAMINE; PARKINSON DISEASE; RATS; SYNUCLEINS;

EID: 0034595728     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02215-0     Document Type: Article

References (49)

1. F.S. Adams, F.G. La Rosa, S. Kumar, J. Edwards-Prasad, S. Kentroti, A. Vernadakis, C.R. Freed, K.N. Prasad, Characterization and transplantation of two neuronal cell lines with dopaminergic properties, Neurochem. Res. 21 (1996) 619-627.
2. A. Athanassiadou, G. Voutsinas, L. Psiouri, E. Leroy, M. Polymeropoulos, A. Ilias, G.M. Maniatis, T. Papapetropoulos, Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding α-synuclein, Am. J. Hum. Genet. 65 (1999) 555-558.
3. M. Baba, S. Nakajo, P.H. Tu, T. Tomita, K. Nakaya, V.M. Lee, J.Q. Trojanowski, T. Iwatsubo, Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies, Am. J. Pathol. 152 (1998) 879-884.
4. E.D. Clarkson, J. Edwards-Prasad, C.R. Freed, K.N. Prasad, In vitro sensitivity of undifferentiated and differentiated immortalized dopamine neurons to neurotoxins is modified by glial cell line-derived neurotrophic factor (GDNF), Proc. Soc. Exp. Biol. Med. 222 (1999) 157-163.
5. E.D. Clarkson, F.G. La Rosa, J. Edwards-Prasad, D.A. Weiland, S.E. Witta, C.R. Freed, K.N. Prasad, Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells, Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 1265-1270.
6. D.F. Clayton, J.M. George, The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease, Trends Neurosci. 21 (1998) 249-254.
7. K.A. Conway, J.D. Harper, P.T. Lansbury, Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkin-son disease, Nat. Med. 4 (1998) 1318-1320.
8. O.M. El-Agnaf, R. Jakes, M.D. Curran, D. Middleton, R. Ingenito, E. Blanchi, A. Pessi, D. Neill, A. Wallace, Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments, FEBS Lett. 440 (1998) 71-75.
9. O.M. El-Agnaf, R. Jakes, M.D. Curran, A. Wallace, Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease, FEBS Lett. 440 (1998) 67-70.
10. S. Engelender, Z. Kaminsky, X. Guo, A.H. Sharp, R.K. Amaravi, J.J. Kleiderlein, R.L. Margolis, J.C. Troncoso, A.A. Lanahan, P.F. Worley, V.L. Dawson, T.M. Dawson, C.A. Ross, Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions, Nat. Genet. 22 (1999) 110-114.
11. 2+-inhibitable adenylyl cyclase in C6-2B glioma cells, J. Biol. Chem. 274 (1999) 12445-12453.
12. J.M. George, H. Jin, W.S. Woods, D.F. Clayton, Characterization of a novel protein regulated during the critical period for song learning in the zebra finch, Neuron 15 (1995) 361-372.
13. B.I. Giasson, K. Uryu, J.Q. Trojanowski, V.M. Lee, Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro, J. Biol. Chem. 274 (1999) 7619-7622.
14. W.R. Gibb, Neuropathology in movement disorders, J. Neurol. Neurosurg. Psychiatry, Suppl. 52 (1989) 55-67.
15. W.R. Gibb, A.J. Lees, The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease, J. Neurol. Neurosurg. Psychiatry 51 (1988) 745-752.
16. Y. Glinka, M. Gassen, M.B. Youdim, Mechanism of 6-hydroxy-dopamine neurotoxicity, J. Neural Transm., Suppl 50 (1997) 55-66.
17. A.M. Gomez-Foix, W.S. Coats, S. Baque, T. Alam, R.D. Gerard, C.B. Newgard, Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hapatocytes confers altered regulation of glycogen metabolism, J. Biol. Chem. 267 (1992) 25129-25134.
18. F.L. Graham, J. Smiley, W.C. Russell, R. Nairn, Characteristics of a human cell line transformed by DNA from human adenovirus type 5, J. Gen. Virol. 36 (1977) 59-72.
19. F.L. Graham, L. Prevec, Methods for construction of adenovirus vectors, Mol. Biotechnol. 3 (1995) 207-220.
20. M. Hashimoto, L.J. Hsu, A. Sisk, Y. Xia, A. Takeda, M. Sundsmo, E. Masliah, Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease, Brain Res. 799 (1998) 301-306.
21. M. Hashimoto, L.J. Hsu, Y. Xia, A. Takeda, A. Sisk, M. Sundsmo, E. Masliah, Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro, Neuroreport 10 (1999) 717-721.
22. L.J. Hsu, M. Mallory, Y Xia, I. Veinbergs, M. Hashimoto, M. Yoshimoto, L.J. Thal, T. Saitoh, E. Masliah, Expression pattern of synucleins (non-Aβ component of Alzheimer's disease amyloid precursor protein/α-synuclein) during murine brain development, J. Neurochem. 71 (1998) 338-344.
23. A. Iwai, E. Masliah, M. Yoshimoto, N. Ge, L. Flanagan, H.A. de Silva, A. Kittel, T. Saitoh, The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system, Neuron 14 (1995) 467-475.
24. M.C. Irizarry, W. Growdon, T. Gomez-Isla, K. Newell, J.M. George, D.F. Clayton, B.T. Hyman, Nigra and cortical Lewy bodies and dystrophic nigral neuntes in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity, J. Neuropathol. Exp. Neurol. 57 (1998) 334-337.
25. P.H. Jensen, P. Hojrup, H. Hager, M.S. Nielsen, L. Jacobsen, O.F. Olesen, J. Gliemann, R. Jakes, Binding of Aβ to α- and βsynucleins: identification of segments in α-synuclein/NAC precursor that binds Aβ and NAC, Biochem. J. 323 (1997) 539-546.
26. R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J.T. Epplen, L. Schols, O. Riess, Ala30 Pro mutation in the gene encoding α-synuclein in Parkinson's disease, Nat. Genet. 18 (1998) 106-108.
27. J.W. Langston, Epidemiology verus genetics in Parkinson's disease: progress in resolving an age-old debate, Ann. Neurol. 44 (1998) 45-52, Suppl.
28. E.H. Lewy, Zur pathologischen Anatomie der Paralysis agitans, Dtsch Z. Nervenheilk 50 (1913) 50-55.
29. E. Mezey, A. Dehejia, G. Harta, M.I. Papp, M.H. Polymeropoulos, M.J. Brownstein, Alpha synuclein in neurodegenerative disorders: Murderer or accomplice, Nat. Med. 4 (1998) 755-757.
30. P.P. Michel, F. Hefti, Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture, J. Neurosci. Res. 26 (1990) 428-435.
31. L. Narhi, S.J. Wood, S. Steavenson, Y. Jiang, G.M. Wu, D. Anafi, S.A. Kaufman, F. Martin, K. Sitney, P. Denis, J.C. Louis, J. Wypych, A.L. Biere, M. Citron, Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation, J. Biol. Chem. 274 (1999) 9843-9846.
32. N. Ostrerova, L. Petrucelli, M. Farrer, N. Mehta, P. Choi, J. Hardy, B. Wolozin, α-Synuclein shares physical and functional homology with 14-3-3 proteins, J. Neurosci. 19 (1999) 5782-5791.
33. S.R. Paik, J.H. Lee, D.H. Kim, C.S. Chang, Y.S. Kim, Self-oligomerization of NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal Aβ fragment (residues 25-35), FEBS Lett. 421 (1998) 73-76.
34. S.R. Paik, H.J. Shin, J.H. Lee, C.S. Chang, J. Kim, Copper (II)induced self-oligomerization of α-synuclein, Biochem. J. 340 (1999) 821-828.
35. A. Papadimitriou, V. Veletza, G.M. Hadjigeorgiou, A. Patrikiou, M. Hirano, I. Anastasopoulos, Mutated α-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance, Neurology 52 (1999) 651-654.
36. J. Parkinson, An essay on the shaking palsy, Sherwood, Neely, and Jones, London, 1817.
37. K. Petersen, O.F. Olesen, J.D. Mikkelsen, Developmental expression of α-synuclein in rat hippocampus and cerebral cortex, Neuroscience 91 (1999) 651-659.
38. V. Picard, S.C. Bock, Rapid and efficient one-tube PCR-based mutagenesis method, in: B.A. White (Ed.), Methods in Molecular Biology, Vol. 67, Humana, Totowa, 1996, pp. 183-188.
39. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, T. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, R.L. Nussbaum, Mutation in the α-synuclein gene identified in families with Parkinson's disease, Science 276 (1997) 2045-2047.
40. O. Riess, R. Kruger, Parkinson's disease - a multifactorial neurodegenerative disorder, J. Neural. Transm., Suppl 56 (1999) 113-125.
41. J. Schaack, S. Langer, X. Guo, Efficient selection of recombinant adenoviruses by vectors that express β-galactosidase, J. Virol. 69 (1995) 3920-3923.
42. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, M. Goedert, α-Synuclein in Lewy bodies, Nature 388 (1997) 839-840.
43. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa, M. Goedert, α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies, Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6469-6473.
44. P.H. Tu, J.E. Calvin, M. Baba, B. Giasson, T. Tomita, S. Leight, S. Nakajo, T. Iwatsubo, J.Q. Trojanowski, V.M. Lee, Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein, Ann. Neurol. 44 (1998) 415-422.
45. K. Ueda, H. Fukushima, E. Masliah, Y. Xia, A. Iwai, M. Yoshimoto, D.A. Otero, J. Kondo, Y. Ihara, T. Saitoh, Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11282-11286.
46. PH. Weinreb, W. Zhen, A.W. Poon, K.A. Conway, P.T. Lansbury, NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded, Biochemistry 35 (1996) 13709-13715.
47. S.J. Wood, J. Wypych, S. Steavenson, J.C. Louis, M. Citron, A.L. Biere, alpha-Synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease, J. Biol. Chem. 274 (1999) 19509-19512.
48. M. Yoshimoto, A. Iwai, D. Kang, D.A. Otero, Y. Xia, T. Saitoh, NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer's disease amyloid, binds Aβ and stimulates Aβ aggregatation, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9141-9145.
49. W.M. Zawada, D.L. Kirschman, J.J. Cohen, K.A. Heidenreich, C.R. Freed, Growth factors rescue embryonic dopamine neurons from programmed cell death, Exp. Neurol. 140 (1996) 60-67.